Chapter 1:
Introduction to Project
Brief Overview of Project:
The report that you are holding in your hand is the result of team work which we have put in to form this research report. The topic of our report is "Reasons and Impacts of Merger ". For that we have focused our studies on the merger of Glaxo Wellcome and SmithKline Beecham forming GlaxoSmithKline. Our objectives behind this research are as follows:
To study the merger that led to the formation of GlaxoSmithKline.
To find out what changes occurred in the operations and business functions after the merger?
To study the organizational structural before and after the merger
To assess the changes in the Human Resource policies and practices of the organization after the merger.
To compare the pre-merger market value of the companies involved in the merger and the current position of the organization in the market after merger.
English: Site for SKB Corporate Headquarters The h...
English: Glaxo Smith Kline's HQ building taken fro...
GlaxoSmithKline Building, Great West Road, Brentfo...To study the legal barriers (if any) and parameters involved in the merger.
Why GlaxoSmithKline:
We have selected to study the merger of Glaxo Wellcome and SmithKline Beecham because GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.
GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio...